NO20005587D0 - Genomiske sekvenser for produksjon og levering av protein - Google Patents

Genomiske sekvenser for produksjon og levering av protein

Info

Publication number
NO20005587D0
NO20005587D0 NO20005587A NO20005587A NO20005587D0 NO 20005587 D0 NO20005587 D0 NO 20005587D0 NO 20005587 A NO20005587 A NO 20005587A NO 20005587 A NO20005587 A NO 20005587A NO 20005587 D0 NO20005587 D0 NO 20005587D0
Authority
NO
Norway
Prior art keywords
delivery
protein production
genomic sequences
genomic
sequences
Prior art date
Application number
NO20005587A
Other languages
English (en)
Other versions
NO20005587L (no
Inventor
Douglas A Treco
Michael W Heartlein
Richard F Selden
Original Assignee
Transkaryotic Therapies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transkaryotic Therapies Inc filed Critical Transkaryotic Therapies Inc
Publication of NO20005587D0 publication Critical patent/NO20005587D0/no
Publication of NO20005587L publication Critical patent/NO20005587L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20005587A 1998-05-07 2000-11-06 Genomiske sekvenser for produksjon og levering av protein NO20005587L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8466398P 1998-05-07 1998-05-07
PCT/US1999/009795 WO1999057263A1 (en) 1998-05-07 1999-05-05 Modifying the expression of the fsh beta gene by homologous recombination

Publications (2)

Publication Number Publication Date
NO20005587D0 true NO20005587D0 (no) 2000-11-06
NO20005587L NO20005587L (no) 2001-01-03

Family

ID=22186422

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005587A NO20005587L (no) 1998-05-07 2000-11-06 Genomiske sekvenser for produksjon og levering av protein

Country Status (18)

Country Link
US (2) US6200778B1 (no)
EP (1) EP1075514A1 (no)
JP (1) JP2002513566A (no)
KR (1) KR20010052279A (no)
CN (1) CN1308673A (no)
AR (1) AR016262A1 (no)
AU (1) AU766620B2 (no)
CA (1) CA2328506A1 (no)
CZ (1) CZ299611B6 (no)
HU (1) HUP0101961A3 (no)
IL (1) IL139432A0 (no)
NO (1) NO20005587L (no)
NZ (1) NZ507459A (no)
PL (1) PL343732A1 (no)
RU (1) RU2229309C2 (no)
TW (1) TWI225517B (no)
WO (1) WO1999057263A1 (no)
ZA (1) ZA200005746B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548296B1 (en) 1997-07-23 2003-04-15 Roche Diagnostics Gmbh Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof
US6897066B1 (en) * 1997-09-26 2005-05-24 Athersys, Inc. Compositions and methods for non-targeted activation of endogenous genes
AU1647501A (en) 1999-12-10 2001-06-18 Cytos Biotechnology Ag Replicon based activation of endogenous genes
JP2002017357A (ja) * 2000-07-04 2002-01-22 Calpis Co Ltd アンカーペプチド、融合蛋白質、及び蛋白質の固定化方法
ES2367257T3 (es) 2002-04-25 2011-10-31 Shire Human Genetic Therapies, Inc. Tratamiento de deficit de alfa-galactosidasa a.
AU2003296438A1 (en) * 2002-12-24 2004-07-29 North Carolina State University Increasing gamete production with a gene switch
KR100533794B1 (ko) * 2003-10-02 2005-12-07 주식회사 프로젠 인간 난포자극 호르몬을 대량으로 생산하는 방법
PT2137655E (pt) 2007-04-16 2012-09-14 Momenta Pharmaceuticals Inc Produtos de glicoproteína definidos e métodos relacionados
CN101397339B (zh) * 2008-09-24 2012-07-25 上海天伟生物制药有限公司 糖蛋白中去除/灭活病毒的方法
EP2325194A1 (en) 2009-11-24 2011-05-25 Glycotope GmbH Process for the purification of glycoproteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639639A (en) * 1983-11-02 1997-06-17 Genzyme Corporation Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
US5272071A (en) * 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
US5968502A (en) 1991-11-05 1999-10-19 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery

Also Published As

Publication number Publication date
PL343732A1 (en) 2001-09-10
KR20010052279A (ko) 2001-06-25
HUP0101961A2 (hu) 2001-10-28
NO20005587L (no) 2001-01-03
EP1075514A1 (en) 2001-02-14
AU766620B2 (en) 2003-10-23
AU3881799A (en) 1999-11-23
NZ507459A (en) 2004-01-30
CA2328506A1 (en) 1999-11-11
TWI225517B (en) 2004-12-21
AR016262A1 (es) 2001-06-20
ZA200005746B (en) 2001-05-17
RU2229309C2 (ru) 2004-05-27
US6200778B1 (en) 2001-03-13
WO1999057263A1 (en) 1999-11-11
CZ20003773A3 (cs) 2001-04-11
US20010034044A1 (en) 2001-10-25
HUP0101961A3 (en) 2003-08-28
IL139432A0 (en) 2001-11-25
WO1999057263A9 (en) 2000-03-02
CN1308673A (zh) 2001-08-15
JP2002513566A (ja) 2002-05-14
CZ299611B6 (cs) 2008-09-17

Similar Documents

Publication Publication Date Title
NO20013536D0 (no) Sammensetninger og fremgangsmåter for mukosal levering
IS2215B (is) Setnar fenýlafleiður, framleiðsla þeirra og notkun
EP1407093A4 (en) DEFLECTION SYSTEM AND METHOD
DE50015539D1 (de) Oligomere und polymere Telechelen
DE60017012D1 (de) Orginalitätsverschluss und Herstellungverfahren
NO20005587D0 (no) Genomiske sekvenser for produksjon og levering av protein
EE200000790A (et) Geeniteraapia meetod
EP1047773A4 (en) CUBILIN PROTEIN, DNA SEQUENCES ENCODING CUBILIN AND THEIR USE
GC0000172A (en) Genomic sequences for protein production and delivery
EP1186615A4 (en) PROTEIN AND DNA OF THIS PROTEIN
DE60010034D1 (de) Methode zur handhabung von 1,1,1,3,3-pentfluoropropan
IT1293418B1 (it) Poliamminotriazina, suo procedimento di produzione ed utilizzo
DK0967286T3 (da) Leucinaminopeptodase-gen
NO20005585D0 (no) Genomiske sekvenser oppströms for den kodende regionen til IFN-ALPHA2 genet for produksjon og levering av protein
IL129734A0 (en) Novel nucleic acid and amino acid sequences
EP1174503A4 (en) NOVEL PROTEINS, GENES ENCODING THEM AND METHODS OF USE
IL128852A0 (en) Novel nucleic acid and amino acid sequences
ATA124999A (de) Mutiertes ribosomales protein l3
EP1433880A4 (en) GALVANOFORMING SYSTEM AND GLAVANEFORMING PROCESS
IL128252A0 (en) Novel nucleic acid and amino acid sequences
EP1122312A4 (en) NEW WAR-1 PROTEIN AND ITS GENE
IL128131A0 (en) Novel nucleic acid and amino acid sequences
AU9227301A (en) Novel proteins, genes encoding them and method of using the same
GB9812793D0 (en) Nucleotide sequences and protein sequences
SE9801035D0 (sv) New DNA sequences and proteins

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application